Trial Profile
A 3 Arm, Double-blind, Placebo-controlled Parallel Group Study to Assess the Efficacy,Safety and Tolerability of Pagoclone for Adults With Stuttering
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 09 Jun 2014
Price :
$35
*
At a glance
- Drugs Pagoclone (Primary)
- Indications Stuttering
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 09 Jun 2014 New trial record